Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-29

Clinical Trial Update: A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive Bladder [NA]

View source ↗

Summary

A sham-controlled clinical trial evaluating a wearable bladder neuromodulation system for overactive bladder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Avation Medical, Inc. | Conditions: Overactive Bladder, Urinary Urge Incontinence | NA | Status: TERMINATED